Genzyme Announces $845-Million Gene Therapy DealByRandi HernandezFebruary 12th 2015Genzyme will partner with Voyager Therapeutics for the discovery, development, and commercialization of novel gene therapies for central nervous system disorders.
AstraZeneca Signs on for CRISPR Gene Editing TechnologyByRandi HernandezJanuary 29th 2015AstraZeneca will team up with various organizations to employ CRISPR technology for precise gene editing in recombinant cell lines.